Australia markets close in 1 hour 55 minutes

Jasper Therapeutics, Inc. (JSPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
22.74-0.23 (-1.00%)
At close: 04:00PM EDT
22.15 -0.59 (-2.59%)
After hours: 07:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 343.49M
Enterprise value 238.99M
Trailing P/E 0.53
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.42
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.42

Trading information

Stock price history

Beta (5Y monthly) 2.23
52-week change 3202.80%
S&P500 52-week change 329.75%
52-week high 331.01
52-week low 34.00
50-day moving average 319.54
200-day moving average 319.07

Share statistics

Avg vol (3-month) 3198.01k
Avg vol (10-day) 3153.04k
Shares outstanding 515.11M
Implied shares outstanding 615.11M
Float 88.83M
% held by insiders 14.95%
% held by institutions 199.01%
Shares short (30 Aug 2024) 42M
Short ratio (30 Aug 2024) 411.73
Short % of float (30 Aug 2024) 413.42%
Short % of shares outstanding (30 Aug 2024) 413.25%
Shares short (prior month 31 July 2024) 41.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 304 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-35.78%
Return on equity (ttm)-59.32%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -67.01M
Net income avi to common (ttm)-62.44M
Diluted EPS (ttm)-60.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)106.82M
Total cash per share (mrq)7.07
Total debt (mrq)2.32M
Total debt/equity (mrq)2.31%
Current ratio (mrq)10.80
Book value per share (mrq)6.64

Cash flow statement

Operating cash flow (ttm)-55.88M
Levered free cash flow (ttm)-34.78M